Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Carty

Showing results (221-230 of 265) with videos related to

Pageof 27
Sort By:
Cancer Cytopathology|August 14, 2012
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinomaN Paul Ohori, Rashi Singhal, Marina N Nikiforova, et al.
Cancer|February 4, 2021
Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control studyLinwah Yip, William E Gooding, Alyaksandr Nikitski, et al.
Annals of Surgical Oncology|May 20, 2011
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancerGina M Howell, Sally E Carty, Michaele J Armstrong, et al.
Thyroid : Official Journal of the American Thyroid Association|March 28, 2023
Molecular Testing Predicts Incomplete Response to Initial Therapy in Differentiated Thyroid Carcinoma Without Lateral Neck or Distant Metastasis at Presentation: Retrospective Cohort StudyJason B Liu, Katherine A Baugh, Kimberly M Ramonell, et al.
Surgery|November 6, 2024
Entrustable Professional Activities in endocrine surgery: A national pilot studyPolina Zmijewski, M Chandler McLeod, Ramsha Akhund, et al.
Cancer Cytopathology|October 18, 2023
Molecular-derived risk of malignancy and the related positive call rate of indeterminate thyroid cytology diagnoses as quality metrics for individual cytopathologistsN Paul Ohori, Jacqueline M Cuda, Sheldon I Bastacky, et al.
Cancer Cytopathology|September 11, 2024
Parsing the thyroid cytopathology suspicious for malignancy diagnosis through molecular-derived risk of malignancy and other related parameters: Insights into nodule characteristics and practice patternsDavid Starr, Youley Tjendra, Jaylou M Velez Torres, et al.
Cancer Cytopathology|August 19, 2014
Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristicsLisa A Radkay, Simion I Chiosea, Raja R Seethala, et al.
Thyroid : Official Journal of the American Thyroid Association|September 11, 2015
Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance CytologyYuri E Nikiforov, Sally E Carty, Simon I Chiosea, et al.
Thyroid : Official Journal of the American Thyroid Association|June 11, 2015
American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision MakingRobert L Ferris, Zubair Baloch, Victor Bernet, et al.
Pageof 27

Showing results (221-230 of 265) with videos related to

Sort By:
Pageof 27
Cancer Cytopathology|August 14, 2012
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinomaN Paul Ohori, Rashi Singhal, Marina N Nikiforova, et al.
Cancer|February 4, 2021
Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control studyLinwah Yip, William E Gooding, Alyaksandr Nikitski, et al.
Annals of Surgical Oncology|May 20, 2011
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancerGina M Howell, Sally E Carty, Michaele J Armstrong, et al.
Thyroid : Official Journal of the American Thyroid Association|March 28, 2023
Molecular Testing Predicts Incomplete Response to Initial Therapy in Differentiated Thyroid Carcinoma Without Lateral Neck or Distant Metastasis at Presentation: Retrospective Cohort StudyJason B Liu, Katherine A Baugh, Kimberly M Ramonell, et al.
Surgery|November 6, 2024
Entrustable Professional Activities in endocrine surgery: A national pilot studyPolina Zmijewski, M Chandler McLeod, Ramsha Akhund, et al.
Cancer Cytopathology|October 18, 2023
Molecular-derived risk of malignancy and the related positive call rate of indeterminate thyroid cytology diagnoses as quality metrics for individual cytopathologistsN Paul Ohori, Jacqueline M Cuda, Sheldon I Bastacky, et al.
Cancer Cytopathology|September 11, 2024
Parsing the thyroid cytopathology suspicious for malignancy diagnosis through molecular-derived risk of malignancy and other related parameters: Insights into nodule characteristics and practice patternsDavid Starr, Youley Tjendra, Jaylou M Velez Torres, et al.
Cancer Cytopathology|August 19, 2014
Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristicsLisa A Radkay, Simion I Chiosea, Raja R Seethala, et al.
Thyroid : Official Journal of the American Thyroid Association|September 11, 2015
Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance CytologyYuri E Nikiforov, Sally E Carty, Simon I Chiosea, et al.
Thyroid : Official Journal of the American Thyroid Association|June 11, 2015
American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision MakingRobert L Ferris, Zubair Baloch, Victor Bernet, et al.
Pageof 27